The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb (Inst); CaP CURE (Inst); Merck (Inst)

Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).
 
Hans J. Hammers
Honoraria - Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb
 
Elizabeth R. Plimack
Consulting or Advisory Role - Astellas Pharma; Dendreon; Genentech; GlaxoSmithKline; Merck; Novartis
Research Funding - Acceleron Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending (Inst)
 
Jeffrey R. Infante
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Marc Ernstoff
No Relationships to Disclose
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Padmanee Sharma
Stock and Other Ownership Interests - Jounce Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; MedImmune
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Albiruni R. A. Razak
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer; Sanofi
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
 
Jennifer L. Spratlin
No Relationships to Disclose
 
Yun Shen
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
 
Paul Gagnier
Employment - Bristol-Myers Squibb
 
Asim Amin
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AB Science; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Prometheus